Goals: To study the long-term outcome after cessation of antiviral therapy in immune-tolerant patients.
Background: Experience in the treatment of immune-tolerant chronic hepatitis B is scanty. Some immune-tolerant patients may receive temporary antiviral therapy, such as for prevention of vertical transmission at pregnancy or prophylaxis for chemotherapy.